INSP Inspire Medical Systems Inc

Price (delayed)

$198.29

Market cap

$5.47B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.55

Enterprise value

$5.3B

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the ...

Highlights
The gross profit has soared by 97% YoY and by 12% from the previous quarter
Inspire Medical Systems's revenue has soared by 95% YoY and by 12% from the previous quarter
The company's quick ratio has shrunk by 57% YoY and by 8% QoQ
INSP's debt is up by 9% YoY

Key stats

What are the main financial stats of INSP
Market
Shares outstanding
27.59M
Market cap
$5.47B
Enterprise value
$5.3B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
24.26
Price to sales (P/S)
20.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.2
Earnings
Revenue
$262.42M
EBIT
-$40.24M
EBITDA
-$38.04M
Free cash flow
-$27.03M
Per share
EPS
-$1.55
Free cash flow per share
-$0.98
Book value per share
$8.18
Revenue per share
$9.54
TBVPS
$10.53
Balance sheet
Total assets
$289.72M
Total liabilities
$64.67M
Debt
$33.6M
Equity
$225.06M
Working capital
$219.31M
Liquidity
Debt to equity
0.15
Current ratio
6.08
Quick ratio
5.51
Net debt/EBITDA
4.46
Margins
EBITDA margin
-14.5%
Gross margin
85.8%
Net margin
-16.2%
Operating margin
-15.3%
Efficiency
Return on assets
-15%
Return on equity
-19%
Return on invested capital
-50.6%
Return on capital employed
-16.3%
Return on sales
-15.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSP stock price

How has the Inspire Medical Systems stock price performed over time
Intraday
3.63%
1 week
19.17%
1 month
16.55%
1 year
1.02%
YTD
-13.81%
QTD
-22.75%

Financial performance

How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$262.42M
Gross profit
$225.12M
Operating income
-$40.22M
Net income
-$42.52M
Gross margin
85.8%
Net margin
-16.2%
The gross profit has soared by 97% YoY and by 12% from the previous quarter
Inspire Medical Systems's revenue has soared by 95% YoY and by 12% from the previous quarter
The operating margin has soared by 63% YoY and by 11% from the previous quarter
INSP's net margin has soared by 62% YoY and by 10% QoQ

Growth

What is Inspire Medical Systems's growth rate over time

Valuation

What is Inspire Medical Systems stock price valuation
P/E
N/A
P/B
24.26
P/S
20.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.2
INSP's EPS is up by 27% year-on-year
The P/B is 50% above the 5-year quarterly average of 16.2 but 13% below the last 4 quarters average of 27.9
Inspire Medical Systems's revenue has soared by 95% YoY and by 12% from the previous quarter
The stock's P/S is 28% less than its last 4 quarters average of 28.9 and 20% less than its 5-year quarterly average of 25.9

Efficiency

How efficient is Inspire Medical Systems business performance
INSP's return on sales has surged by 63% year-on-year and by 11% since the previous quarter
INSP's ROA is up by 28% YoY
INSP's ROE is up by 24% year-on-year
INSP's ROIC is up by 14% YoY but it is down by 9% from the previous quarter

Dividends

What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSP.

Financial health

How did Inspire Medical Systems financials performed over time
The company's quick ratio has shrunk by 57% YoY and by 8% QoQ
The current ratio has dropped by 55% year-on-year and by 6% since the previous quarter
INSP's debt is 85% lower than its equity
INSP's debt is up by 9% YoY
INSP's debt to equity is up by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.